ASCML
PFE icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Pfizer PFE Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.5K Hold
2,511
– – 0.05% 132
2026
Q1 		$70.5K Sell
2,511
-154
-6% -$4.1K 0.07% 121
2025
Q4 		$66.4K Buy
+2,665
New +$67.2K 0.07% 119

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's PFE Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its Pfizer (PFE) position steady in Q2 2026 at 2,511 shares worth $60.5K. The position accounts for 0.05% of the portfolio, ranked #132.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $70.5K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 2,511 shares of Pfizer worth $60.5K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.05% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #132 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC's Pfizer position peaked at $70.5K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.